NuVasive, Inc. NUVA, a medical device company focused on developing minimally
disruptive surgical products and procedures for the spine, announced
today the Japanese approval of the CoRoent Large Impacted (LI) and
CoRoent Large Tapered (LT) titanium alloy implants. The implants are
used in posterior spine fusion procedures and are NuVasive's first
two interbody fusion cages to be approved in Japan. The approvals
further the Company's ability to participate in the world's second
largest spine market with certain cervical solutions and a
comprehensive posterior product offering, which have already been
cleared for use.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in